相关实验视频

Updated: Jun 23, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

复发性抗GAD65相关脑炎对胸腺瘤切除,辐射和免疫调节疗法有反应

Jonathan D Krett¹, Maria E Molinaro¹, Justin C McArthur^1,2,3

¹Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

The Neurohospitalist

|June 19, 2024

概括

这项案例研究突出了反复复发的抗GAD65脑炎,该脑炎对胸腺瘤切除,放射治疗和免疫治疗有反应. 针对瘤的治疗可能会提高超出单独免疫治疗的结果.

科学领域:

神经免疫学神经免疫学
在瘤学瘤学.

背景情况:

抗谷氨酸脱酶65 (anti-GAD65) 抗体与自身免疫性脑炎有关.
胸腺瘤是一种已知与抗-GAD65抗体的副瘤关联.

研究的目的:

描述一个反复复发的抗GAD65脑炎病例.
评估治疗对多模式治疗的反应,包括针对瘤的干预措施.

主要方法:

一个患有复发性抗GAD65脑炎的病人的病例报告.
治疗包括胸腺瘤切除,外部光束放射治疗和免疫调节疗法.

主要成果:

患者对综合治疗方法表现出反应.
针对瘤的治疗似乎提供了额外的益处.

结论:

在与抗GAD65抗体相关的疾病中对形综合征的警至关重要.
多模式治疗,包括瘤导向疗法,可能对耐火病例有益.

关键词:

影像成像技术影像成像技术神经系统神经系统神经免疫学神经免疫学麻性综合征麻性综合征

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.